Seeing Medicines
Latest round
- Seed
Last raised
- Jun 2021
Total raised
- $6M
Investors
- 1
About Seeing Medicines
Based in North Carolina, US, and founded in 2020, Seeing Medicines, Inc. develops regenerative medicine treatments to restore and maintain vision in people with macular degenerative diseases. Leroux Jooste is the CEO and President of the company as of 2021. The company is developing novel cellular therapeutics to treat AMD (Age-related Macular Degeneration), Best Disease, Stargardt Disease, and other macular degenerative illnesses. SMI-001, a comprehensive therapy system for macular degeneration illnesses, is the company's flagship product. Seeing Medicines, Inc.
Who invested in Seeing Medicines
1 investor across 1 round
See all investors in Seeing Medicines
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jun 11, 2021
Amount
$6M
Investors
Questions about Seeing Medicines
Who invested in Seeing Medicines?
Seeing Medicines has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Seeing Medicines raised?
Seeing Medicines has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Seeing Medicines last raise money?
Seeing Medicines's most recent round on record is a Seed, in Jun 2021.
What does Seeing Medicines do?
Based in North Carolina, US, and founded in 2020, Seeing Medicines, Inc.
Where is Seeing Medicines headquartered?
Seeing Medicines is headquartered in Arden, US.
Which VCs invest in companies like Seeing Medicines?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Seeing Medicines's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Seeing Medicines? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.